GlassScriptPhysician profile
Elizabeth D Avaricio
NPI 1477535300
$3,008.00
in general payments reported to CMS, 2019-2025
19 companies · $578 in 2025
The $578 reported for 2025 was more than what 95% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $41.69 · 2021: $161 · 2022: $571 · 2023: $289 · 2024: $665 · 2025: $578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,479 · Travel and Lodging: $53.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.52 |
| Travel and Lodging | $53.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $590.10 | 2019-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Medtronic, INC. | $515.44 | 2022-2023 | Avalus |
| Pfizer INC. | $279.07 | 2019-2025 | |
| Glaxosmithkline, LLC. | $250.38 | 2019-2025 | Bexsero |
| Kowa Pharmaceuticals America, INC. | $248.81 | 2024-2025 | Zoryve |
| Cumberland Pharmaceuticals, INC. | $209.02 | 2019-2025 | Kristalose |
| Kaleo, INC. | $198.58 | 2022-2024 | Auvi-Q |
| Sanofi Pasteur INC. | $151.10 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Phadia US INC. | $69.13 | 2019-2024 | Immunocap |
| E.R. Squibb & Sons, L.L.C. | $61.52 | 2022 | |
| Boston Scientific Corporation | $50.20 | 2019 | |
| Aytu Biopharma, INC. | $33.55 | 2025 | |
| Seqirus USA INC | $24.74 | 2024 | Flucelvax |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $20.91 | 2025 | Doc Band |
| Cipher Pharmaceuticals US LLC | $19.62 | 2025 | Spinosad, Natroba |
| Alk-Abello, INC | $18.22 | 2025 | Neffy |
| Sobi, INC | $17.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Avaricio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.